Diagnostics Solutions Strategic Priorities
Supporting patient journeys with our oncology portfolio
Sales of oncology reagents surpassing CHF 1.8 bn in 2020
Roche
Screening
Diagnosis & Classification
Prognosis¹
Therapy selection²
Monitoring/Surveillance
8
250+
5
2
1
10
7
5
3
13
1
www
IA
(CA 19-9)
A
IHC
(Ki67)
Π
PCR
(EGFR)
Algorithms
IA
(CA 19-9)
IHC
(Ki67)
PCR
(EGFR)
Algorithms
IA
(CA 19-9)
IHC
(Ki67)
NGS
Algorithms
IA
(CA 19-9)
IHC
(Ki67)
PCR
(EGFR)
NGS
Algorithms
IA
(CA 19-9)
PCR
(EGFR)
NGS
Algorithms
3
1
1
1 Predicting the likely or expected development of a disease
2 On-label CDx indications
Polymerase Chain Reaction (PCR)
Algorithms
Decision support: NAVIFY Mutation Profiler, NAVIFY Tumor Board, NAVIFY guidelines
Immunoassay (IA)
Immunohistochemistry (IHC)
Next Gen Sequencing (NGS)
XIM
64
64View entire presentation